“World TB day and TB in Mongolia”

Slides:



Advertisements
Similar presentations
DOTS/ DOTS PLUS IMPLEMENTATION AND INTEGRATION Vaira Leimane State Centre of Tuberculosis and Lung Diseases of Latvia Paris, October, 28.
Advertisements

Planning M&E to Tell Our ACSM Story. Objectives Discuss how ACSM activities can address barriers to help reach national TB control targets. Describe how.
Planning in line with the Stop TB Strategy and the Global Plan to Stop TB, Dr Win Maung Programme Manager National Tuberculosis Programme Ministry.
From DOTS to the Stop TB Strategy Building on Achievements for Future Planning Stop TB Partnership Symposium at the 37 th UNION World Conference on TB.
PPM-DOTS in Cambodia Working with Private Pharmacies DOTS Expansion WG Meeting Paris 15 th October 2008 Dr. Mao Tan Eang Director National Center for TB.
Improving diagnosis TB laboratory strengthening.
Ram Deo Chaudhary Programme Manager, BNMT. Outlines VMGO of BNMT Guiding principles of partnership Historical background Current efforts Strengths Area.
1 [INSERT COUNTRY NAME HERE] Introduction to the National MDR-TB Control Strategy SESSION 1 Insert country/ministry logo here.
Washington D.C., USA, July 2012www.aids2012.org A National Program Manager’s Perspective on HIV/TB Integration Dr Owen Mugurungi Director – AIDS.
Accelerating PMDT scale up in Ethiopia
GUIDELINES & TOOLS for HOSPITAL DOTS LINKAGE (HDL)
Country Progress Report Philippines
Introduction Thailand one of 22 countries which contain 80% of the estimated tuberculosis (TB) cases in the world. Thailand ranks 17 th among the 22 high-burden.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Country Progress Report VIET NAM
COUNTRY XEPERIENCE AND RESPONSE TO MDR AND XDR TUBERCULOSIS PRESENTED AT THE WHO TB/HIV PLANNING MEETING, ADDIS ABBABA, 11-12, NOVEMBER 2008 BY MS GUGU.
Revised National Tuberculosis Control Programme (RNTCP)
National Mental Health Programme. Govt of India integrated mental health with other health services at rural level. It is being implemented since 1982.
African Business Leaders on Health GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 2010 Technical Assistance.
MDR-TB: a fight we cannot afford to lose! Alexander Golubkov, MD, MPH Senior TB Technical Advisor.
Unit 9. Human resource development for TB infection control TB Infection Control Training for Managers at National and Subnational Level.
Challenge 4: Linking TB & HIV/AIDS Programs Kayt Erdahl, Project HOPE Rodrick Nalikungwi, Project HOPE Malawi December 18, 2008.
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
Mongolia Progress Report Dr. D. Otgontsetseg, Head of recording and reporting unit, TB surveillance and research department, NCCD The ninth Technical Advisory.
Improving TB-DM Care in the Pacific: Partnerships and Progress R. Brostrom, MD-MSPH Hawaii TB Control Branch Chief Regional TB Field Medical Officer, CDC-DTBE.
Progress and Plans for PPM in the Western Pacific Region Fifth PPM DOTS Subgroup Meeting Cairo, Egypt.
FINANCIAL OPTIONS FOR TB CONTROL IN MONGOLIA
A decentralized model of care for drug-resistant tuberculosis in a high HIV prevalence setting Cheryl McDermid, Helen Cox, Simiso Sokhela, Gilles van Cutsem,
Regional Advocacy, Communication and Social Mobilization Planning Workshop for Tuberculosis Control Amman, Jordan April 2008 Regional Advocacy, Communication.
The implementation of the National Tuberculosis Control Program at a regional level: Voronezh TB Service JULY 13, 2015 Dr. Kornienko, Sergey.
Group discussion Urban Slums Rapporteur: Joseph K Sitienei Facilitators: B. Squire, I. Onozaki.
TB PUBLIC-PRIVATE MIX DOTS Dr. Team Bakkhim Deputy Director CENAT Intercontinental Hotel 7 th November, 2012 NATIONAL FORUM ON PUBLIC-PRIVATE PARTNERSHIP.
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.
Overview of Advocacy, Communication, and Social Mobilization.
U pdates on the development of the NTP National Strategic Plan GC National TB Conference Pokhara, July 14-15, 2014 Giampaolo Mezzabotta Medical.
Session 11: MDR & XDR-TB: How Can Business Help Stem the Tide?
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
Dr. Hind E. Satti Partners In Health, Lesotho March, 2008.
Japan Dr. Ismail M. Aboshama Zidan Surveillance Coordinator of NTP-Egypt Action Plan to Strengthen Laboratory Diagnostic.
1 Oct 2005 WHO/STB/THD World Health Organization 4 th Meeting of Subgroup on laboratory capacity strengthening Paris, France, October Ernesto Jaramillo.
PMDT expansion is first of all expansion of DR-TB detection services Workshop on the development and implementation of supervision and patient support.
Dana Farcasanu Foundation Center for Health Policies and Services
Public Health. TB-DOTS program Government commitment Case detection by DSSM among symptomatic patients self-reporting to health services Standard short-course.
DEWG Meeting Geneva 14 October 2009 TB in children Report from the breakout session.
Progress and plans for PPM in the WHO Region of the Americas Fifth PPM Subgroup Meeting June, Cairo.
PERSPECTIVES FROM THE FIELD DR LYDIA MUNGHERERA TASO (The Aids Support Organisation) UGANDA REVERSING THE TIDE OF TB.
National Tuberculosis Control Program in Bangladesh : Progress Report Dr. Shamim Sultana Deputy Programme Manager, TB National TB Control Programme.
Exploring financing options NATIONAL TB CONTROL OF VIETNAM.
Contribution of operational research in China National Center for TB Control and Prevention, China CDC Jiang Shiwen Cancun.
TB infection control and prevention of XDR Group II.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
Introduction of outpatient care for DS-/MDR-TB patients in Tajikistan Cape Town, December 02-06, 2015.
Global Fund Grant Proposal Round 11: Tuberculosis Nathan Furukawa Gabriella Boyle Rebekah Miner Paa Kobina Forson Xiaoxue Huang Hunter Pugh Gap Analysis.
Measures to Decrease TB Prevalence in the Barents Region Andrey O. Maryandyshev Elena I. Nikishova Dmitry V. Perkhin.
Gap Analysis: Tuberculosis Care in Malawi Round 11 proposal to the Global Fund to Fight AIDS, Tuberculosis and Malaria Africa 3: Team Malawi Arianna, Babatunde,
PMDT IN CHINESE TAIPEI ECONOMY Anita Pei-Chun Chan, MD, PhD Medical Officer, TCDC Associated Director, TB Research Center, TCDC Assistant Professor, Institute.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Challenges and Constraints for TB Control in Kenya Dr. James Nyikal Director of Medical Services, Kenya.
Stop TB in China Challenges, Constraints & Actions Dr Wang Longde Vice Minister of Health China 24 March 2004.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
Taipei, June Content  Introduction about Vietnam’s Programmatic Management of Drug resistant Tuberculosis (PMDT) and drug resistant tuberculosis.
Thailand experience in implementing collaborative HIV/TB activities Anupong Chitwarakorn, MD Ministry of Public Health, Thailand TB/HIV Satellite symposium.
TB/ HIV CONTROL AND MANAGEMENT IN SOUTH AFRICA
TB- HIV Collaborative activities in Romania- may 2006 status
Prisons and TB in Europe
Country Progress Report Cambodia
TB/HIV surveillance : Who is going to get the job done?
Key issues in DOTS implementation
Update on SBCC Activities of Challenge TB Bangladesh
The STOP TB Strategy – 2009 VISION: A TB-free world
Presentation transcript:

“World TB day and TB in Mongolia” O.Batbayar MD,MPH (University of London) National Tuberculosis Program

World TB day-Stop TB in my Life Time

2012 оны Сүрьеэтэй Тэмцэх Өдөр

TB in Mongolia Mongolia is one of the 7th high burden TB country in West Pacific region of WHO. 3985 cases last year per 2.7 population ( 12000 cases per 270 mln USA population) 185 MDR cases Total 19 XDR cases 400 paediatric cases TB incidence 219 per 100000 TB prevalence 280 per 100000 TB Mortality 21 per 100000 2011 statistics is promising

Last ten years incidence, treatment success and mortality

Last ten years incidence and treatment success

Timeline 1968: The TB laboratory was established 1992: The TB laboratory network was developed 1994: NTP was established and DOTS launched 1994: Organization of the National Reference Laboratory 1997: Quality assurance system was introduced, Supranational Reference Laboratory (SRL) Japan 1997: First Drug Resistance Survey (DRS) conducted 1999: 100% DOTS coverage 2001:Reogranization of the TB Department under the National Center for Communicable Disease (NCCD) 2001: GFATM Round1 launched, later on RCC1 2002: National Programme of Communicable Diseases (NPCD) approved, TB program is a sub-programme of the NPCD 2005: GFATM Round 4 launched, Later on RCC 4 2006: launching of GLC approved project for management of 375 patients with drug-resistant TB (DR-TB) 2007: Second DRS conducted 2008: The review of the NTP 2009: Testing of drug resistance to second-line anti-TB drugs (SLD) started 2010: second National Programme of Communicable Diseases (NPCD) approved for the years 2010-2015, TB program is a sub-programme of the NPCD 2010: National strategic plan to stop TB in Mongolia, 2010-2015 (Objective 3-expand programmatic management of MDR-TB) 2010: Updated the guidelines on tuberculosis care and service (appendix 3- guidelines on drug resistant TB services and care) approved by MOH, 2010 2010: National TB Infection control (IC) guidelines developed and approved 2010: GLC approved second cohort for 790 patients 2011: GFATM Round 10 approved and the consolidated grant will be launched in July 2011 2012 ; ACSM strategy is in development process

Current TB situation Political and financial commitment National strategic plan to stop TB in Mongolia (Objective 3-expand programmatic management of MDR-TB), MoH, 2009 National guidelines on tuberculosis care and service updated and approved by MoH, 2009 (appendix 3- guidelines on drug resistant TB services and care) Successful resource mobilization from the GFATM (since 2006 –present, single stream funding)

MDR-TB patients enrolled (2003- 2011) MDR-TB estimates burden by WHO: 106 new MDR-TB cases every year BUT BY END OF 2011 – WE DIAGNOSED 180 First three month of 2012 – 22 new cases DRS survey 2007: among new cases: 1.4% Among retreatment cases 27.5% 893 MDR-TB cases were diagnosed, out of them: 58.1% (519) have been enrolled to treatment, 26.5% (237) died, and 1.3% (12) refused treatment, 1.1% (10) were treated abroad or private hospital, 0.8% (7) were not able to be enrolled in treatment due co-morbidities, 12.1% (108) were on the waiting list.

National TB reference laboratory with 37 branches and sputum transportaion scheme

Current MDR-TB situation Available infrastructure: NTRL (DST, culture, liquid culture, LPA on FLDs) Treatment is available through GFATM support Infection control: Administrative measures General infection control order, approved by MoH, 2010 TB infection control guidelines, 2010

Treatment success rate Treatment outcomes Final outcomes for 2008 cohort Year Total Cured Treatment completed Failed Defaulted Died Cure rate Treatment success rate 2006 50 21(42.0) 11(22.0) 8 (16.0) 2(4.0) 8(16.0) 42.0 64.0% 2007 64 40(62.5) 9(14.1) 4(6.3) 6(9.4) 5(7.8) 62.5 76.6% 2008 65 48(73.8) 2(3.1) 3(4.6) 6(9.2) 73.8 76.9% 179 109(60.9) 22(12.3) 15(8.4) 14(7.8) 19(10.6) 60.9 73.6%

Partners World Vision International Mongolia (WVIM) started the implementation of the GF TB grants since 2005. It has been collaborating with the “Enerel” charity and Prison Hospital on provision of TB care services for vulnerable population as homeless and prisoners, conducting active case finding and ACSM activities Mongolian Anti-Tuberculosis Association (MATA) worked as sub-recipient (SR) for GF supported project since 2003 on the implementation of home-based and lunch-DOT for TB patients through trained health volunteers nationwide. Also they led ACSM activities for general population as well as for patients and their family to reduce stigma and discrimination against TB. Mongolian Association of Family Clinics (MAFC) implemented the PPMD since April 2009 within the Round 1 RCC. The MAFC has been carrying out the following interventions: training TOT among family physicians on early detection and treatment, referral of TB suspects to a secondary and tertiary level of TB services, transportation of sputum samples from primary health care services to TB dispensaries, and developing clinical guidelines for family doctors

Partners Mongolian Antituberculosis Union newly formed in 2011 Health Science University of Mongolia (HSUM) collaborates closely with the NTP on the revision of the curriculum of relevant health sciences courses including medical course, nursing and pharmacy. The HSUM is instrumental in on formalizing of policy documents in collaboration with the Ministry of Education. The GFATM provides financial support World Health Organization (WHO) provides technical assistance through its Country and Regional Offices.

Strength and Weakness Strengths of T B Control Program Good and detailed National Strategic Plan to Stop TB in Mongolia (2010-2015) KAP survey for health providers completed and published KAP survey with general population in final stages Partnerships in place and community mobilization Commitment of staff and available technical support Challenges in TB Control Program Human resources (all) Limited knowledge of TB (all) Stigma and discrimination (all) Coordination Significant amount of data but not used appropriately, TB prevalence survey not contacted Engaging all providers/community groups Political commitment

Challenges and some factors Various vulnerable groups (homeless, alcoholics, poor) difficult to reach Seeking diagnosis late Treatment default Infection Control practices/guidelines not implemented No diversified funding for TB control activities Limited knowledge on TB (all) and availability of services among population Limited knowledge on Interpersonal Communication and Counseling skills (providers) Lack of target specific messaging on TB No coordination or/and consistency of TB messages among partners Coordination, planning, partnerships, networks No standardized training curriculum and tools for providers and community volunteers Health providers have no interest to work in TB sector Currently limited efforts to gain political support for TB

Best TB Dispensary

TB HR seminar and Paediatric department

TB day HRD strategy ACSM strategy TB patient social care and isolation KAP survey TB incidence among HCW MoU with high burden districts TB registration web Media and web Activity among TB patients AXA among school children Debjee- amongTB Voluntary Workers TV education program

Thank you